CAPRA Annual Education Day 2026

Dr. Guerra brings more than 10 years of experience in the pharmaceutical industry, working in Research and Development and Regulatory Affairs. She has managed several successful regulatory submissions to Health Canada and the United States (US) Food and Drug Administration (FDA), including Investigational New Drugs (INDs), Abbreviated New Drug Applications (ANDAs), and New Drug Applications (NDAs). Dr. Guerra has a strong understanding of quality and Good Manufacturing Practices (GMPs), which she leverages when implementing Chemistry, Manufacturing, and Controls (CMC) strategy. In her current role as Associate Director of Regulatory Affairs at SGS Nutrasource, she provides scientific and regulatory support on existing projects, as well as during the evaluation of new business opportunities. As Scientific & Technical Committee Lead and Regulatory Committee Lead, Paula works closely with the Global Prebiotic Association (GPA). 

Dr. Guerra holds a PhD in Analytical Chemistry by the University of Barcelona. She studied emerging contaminants and their impact on the environment and humans. She is a published author of 25 peer-reviewed journal articles and two book chapters.

Soumitra has supported sponsors across North America, Europe, and Asia within the contract research and regulatory consulting sector, contributing to a global portfolio of client engagements. He has worked with many organizations across multiple product categories, including foods, natural health products, dietary supplements, and over-the-counter (OTC) products. His experience includes advising companies on clinical study feasibility and selecting appropriate research pathways based on intended claims and market entry strategy. Soumitra holds a Bachelor of Science (BSc), Master of Business Administration (MBA), and a Master of Public Health (MPH). His multidisciplinary background allows him to bridge scientific, regulatory, and commercial perspectives, translating complex technical considerations into clear, practical guidance for sponsors.